| The novel butyrate derivative phenylalanine‐butyramide protects from doxorubicin‐induced cardiotoxicity M Russo, F Guida, L Paparo, G Trinchese, R Aitoro, C Avagliano, ... European journal of heart failure, 2019 | 91 | 2019 |
| Tumour microenvironment and immune evasion in EGFR addicted NSCLC: hurdles and possibilities A Santaniello, F Napolitano, A Servetto, P De Placido, N Silvestris, ... Cancers 11 (10), 1419, 2019 | 61 | 2019 |
| Role of FGFR3 in bladder cancer: Treatment landscape and future challenges CM Ascione, F Napolitano, D Esposito, A Servetto, S Belli, A Santaniello, ... Cancer Treatment Reviews 115, 102530, 2023 | 52 | 2023 |
| Mechanisms of resistance to mTOR inhibitors L Formisano, F Napolitano, R Rosa, V D’Amato, A Servetto, R Marciano, ... Critical reviews in oncology/hematology 147, 102886, 2020 | 41 | 2020 |
| Neoadjuvant treatment in locally advanced pancreatic cancer (LAPC) patients with FOLFIRINOX or gemcitabine nabpaclitaxel: a single-center experience and a literature review F Napolitano, L Formisano, A Giardino, R Girelli, A Servetto, A Santaniello, ... Cancers 11 (7), 981, 2019 | 41 | 2019 |
| Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists M Ottaviano, M Curvietto, P Rescigno, M Tortora, G Palmieri, ... Journal for Immunotherapy of Cancer 8 (2), 2020 | 20 | 2020 |
| Toxicity profile of antibody-drug conjugates in breast cancer: Practical considerations A D’Arienzo, A Verrazzo, M Pagliuca, F Napolitano, S Parola, M Viggiani, ... EClinicalMedicine 62, 2023 | 15 | 2023 |
| Inadequate health-related quality of life assessment and reporting in phase III clinical trials of immune checkpoint inhibitors in solid cancers: A systematic review A Servetto, F Salomone, F Di Costanzo, R Iuliano, L Marandino, ... Critical Reviews in Oncology/Hematology 172, 103649, 2022 | 15 | 2022 |
| A review of the use of next generation sequencing methodologies to identify biomarkers of resistance to CDK4/6 inhibitors in ER+/HER2-breast cancer A Servetto, F Napolitano, C De Angelis, P De Placido, M Giuliano, ... Critical Reviews in Oncology/Hematology 157, 103191, 2021 | 14 | 2021 |
| RET rearrangements in non-small cell lung cancer: Evolving treatment landscape and future challenges A Servetto, D Esposito, R Ferrara, D Signorelli, S Belli, F Napolitano, ... Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1877 (6), 188810, 2022 | 10 | 2022 |
| History of how viruses can fight cancer: from the miraculous healings to the approval of oncolytic viruses M Bifulco, E Di Zazzo, F Napolitano, AM Malfitano, G Portella Biochimie 206, 89-92, 2023 | 9 | 2023 |
| Conformational consequences of NPM1 rare mutations: An aggregation perspective in Acute Myeloid Leukemia S La Manna, D Florio, C Di Natale, F Napolitano, AM Malfitano, PA Netti, ... Bioorganic Chemistry 113, 104997, 2021 | 8 | 2021 |
| Small molecules enhancers of amyloid aggregation of C-terminal domain of Nucleophosmin 1 in acute myeloid leukemia D Florio, V Roviello, S La Manna, F Napolitano, AM Malfitano, D Marasco Bioorganic Chemistry 127, 106001, 2022 | 7 | 2022 |
| Insight on the role of leptin: a bridge from obesity to breast cancer R Buonaiuto, F Napolitano, S Parola, P De Placido, V Forestieri, ... Biomolecules 12 (10), 1394, 2022 | 7 | 2022 |
| Health-related quality of life is underestimated and underreported in phase III clinical trials in NSCLC F Salomone, F Di Costanzo, G Pecoraro, G Viscardi, A Viggiano, ... Lung Cancer 174, 36-44, 2022 | 6 | 2022 |
| Combination of dl922-947 Oncolytic Adenovirus and G-Quadruplex Binders Uncovers Improved Antitumor Activity in Breast Cancer F Napolitano, S Di Somma, G Castellano, J Amato, B Pagano, ... Cells 11 (16), 2482, 2022 | 6 | 2022 |
| Cross talk of macrophages with tumor microenvironment cells and modulation of macrophages in cancer by virotherapy S Di Somma, F Napolitano, G Portella, AM Malfitano Biomedicines 9 (10), 1309, 2021 | 6 | 2021 |
| FOLFIRINOX after first-line gemcitabine-based chemotherapy in advanced pancreatic cancer: a retrospective comparison with FOLFOX and FOLFIRI schedules F Foschini, F Napolitano, A Servetto, R Marciano, E Mozzillo, AC Carratù, ... Therapeutic Advances in Medical Oncology 12, 1758835920947970, 2020 | 6 | 2020 |
| Immunological signature of patients with thymic epithelial tumors and Good syndrome AM Malfitano, V D’Esposito, P De Placido, M Tortora, M Ottaviano, ... Frontiers in Immunology 13, 908453, 2022 | 5 | 2022 |
| Synthesis and In Vitro Characterization of Selective Cannabinoid CB2 Receptor Agonists: Biological Evaluation against Neuroblastoma Cancer Cells F Gado, R Ferrisi, S Di Somma, F Napolitano, KA Mohamed, ... Molecules 27 (9), 3019, 2022 | 5 | 2022 |
